Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 3
1998 1
1999 3
2000 6
2001 12
2002 8
2003 6
2004 10
2005 14
2006 10
2007 14
2008 13
2009 5
2010 3
2011 3
2012 3
2013 3
2015 2
2016 2
2017 2
2019 3
2023 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 15865101

113 results
Results by year
Filters applied: . Clear all
Page 1
Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study.
Casal J, Amenedo M, Mel JR, Antón LM, Rodríguez-López R, López-López R, González-Ageitos A, Castellanos J, Constenla M, Tisaire JL. Casal J, et al. Cancer Chemother Pharmacol. 2007 Oct;60(5):725-32. doi: 10.1007/s00280-007-0418-7. Epub 2007 Feb 2. Cancer Chemother Pharmacol. 2007. PMID: 17273825 Clinical Trial.
Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
Cobo Dols M, Villar Chamorro E, Alés Díaz I, Gil Calle S, Alcalde García J, Gutiérrez Calderón V, Carabantes Ocón F, Montesa Pino A, Bretón García JJ, Benavides Orgaz M. Cobo Dols M, et al. Clin Transl Oncol. 2006 Oct;8(10):742-9. doi: 10.1007/s12094-006-0121-x. Clin Transl Oncol. 2006. PMID: 17074673 Clinical Trial.
Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study.
Kakolyris S, Papadakis E, Tsiafaki X, Kalofonos C, Rapti A, Toubis M, Bania E, Kouroussis C, Chainis K, Androulakis N, Agelaki S, Sarra E, Vardakis N, Georgoulias V; Greek Cooperative Group for Lung Cancer. Kakolyris S, et al. Lung Cancer. 2001 May;32(2):179-87. doi: 10.1016/s0169-5002(00)00212-9. Lung Cancer. 2001. PMID: 11325489 Clinical Trial.
113 results